Search alternatives:
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
age decrease » a decrease (Expand Search), larger decrease (Expand Search), rate decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
i means » _ means (Expand Search), k means (Expand Search)
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
age decrease » a decrease (Expand Search), larger decrease (Expand Search), rate decreased (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
i means » _ means (Expand Search), k means (Expand Search)
-
1
Maternal group B <i>Streptococcus</i> decreases infant length and alters the early-life microbiome: a prospective cohort study
Published 2024“…</p> <p>GBS exposure is associated with decreased infant length growth, with altered microbiota and metabolites potentially mediating the effects of maternal GBS on offspring length growth, offering potential targets for predicting and addressing growth impairment.…”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Factors associated with AL score (multivariable regression analyses for the third follow-up).
Published 2025Subjects: -
9
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
10
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
11
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
12
Annual treatment frequencies in all eyes.
Published 2025“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
13
Annual number of outpatient visits in all eyes.
Published 2025“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
14
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025“…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”
-
15
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”
-
16
-
17
-
18
-
19
-
20